Literature DB >> 21923306

Observation on validity of the five-tier system for fetal heart rate pattern interpretation proposed by Japan Society of Obstetricians and Gynecologists.

Atsuko Sadaka1, Madoka Furuhashi, Hiroji Minami, Ken Miyazaki, Kana Yoshida, Kaoru Ishikawa.   

Abstract

OBJECTIVE: To evaluate the five-tier classification of fetal heart rate (FHR) tracings recently proposed by Japan Society of Obstetricians and Gynecologists (JSOG).
METHODS: The database between January and June 2009 was reviewed for women in active labor at ?36 + 0 gestational weeks, with singleton fetuses in cephalic presentation and with umbilical artery blood gas analyses. Continuous FHR tracings were assessed according to the five-tier classification proposed by JSOG, where level 1 is normal, level 2 is subnormal and levels 3?5 are abnormal patterns.
RESULTS: A total of 341 parturient women were eligible for this study protocol. The median (range) of the levels in the first and the second stage of labor were 1 (1-4) and 2 (1-4), respectively (p < 0.001). Both pH and base excess of umbilical artery decreased with higher levels of FHR tracings interpretation (p < 0.01). Interventions resulting in delivery were more necessary in the first stage of labor than in the second stage of labor in cases of levels 3 and more.
CONCLUSIONS: Five-tier system for FHR tracing interpretation proposed by JSOG intercorrelates with the fetal acid-base balance well. Categorization of FHR tracings by uniform diagnostic criteria will be useful to standardize therapeutic strategy by sharing common perception among obstetrical staff.

Entities:  

Mesh:

Year:  2011        PMID: 21923306     DOI: 10.3109/14767058.2011.621999

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Evaluation of 3-tier and 5-tier FHR pattern classifications using umbilical blood pH and base excess at delivery.

Authors:  Hitomi Kikuchi; Shunichi Noda; Shinji Katsuragi; Tomoaki Ikeda; Hiroyuki Horio
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.